Literature DB >> 17976937

Oral care experiences with 181 nasopharyngeal carcinoma patients receiving radiotherapy in a Taiwanese hospital.

Wen-Chen Wang1, Yuk-Kwan Chen, Li-Min Lin.   

Abstract

OBJECTIVE: The aim of this study is to present our experiences of the oral care of a cohort of nasopharyngeal carcinoma (NPC) patients before receiving radiation therapy in our institution. PATIENTS AND METHODS: A total of 181 (141 males and 40 females) pre-radiation therapy NPC patients who underwent regular recall dental examination and treatment according to a standard protocol of our Dental Department were collected.
RESULTS: One hundred and twelve (68.71%) did not have disease recurrence and only 12 patients (7.36%) had metastasis. The rate of expire was 14.92%. The average number of carious tooth was 2.45 (range: 0-16) whereas the mean number extracted tooth was 2.65 (range: 0-14). One hundred and sixty-four patients were recorded to have suffered from oral mucositis. About 7% patients had oral mucositis in the 1st week, but about 50% of patients developed oral mucositis from the 2nd week to the 3rd week after the beginning of radiotherapy. One hundred and thirty-three patients had records of oral infection. About 67% of the patients suffered from candidiasis during radiotherapy. Xerostomia was found in almost 80% of patients during radiation therapy. The mean number of carious tooth of the patient population during/after radiation therapy was significantly higher than the patient population before radiation therapy (7.18+/-7.10 vs. 2.45+/-2.85; chi2=46.32, p<0.0001). Eighty-four patients were regularly followed-up and the rate of lost follow-up was about 53.6%. One hundred and eighteen patients had custom-made fluoride trays fabricated. As comparing patients with fluoride trays to those without, the former had a significantly higher rate of dental follow-up compliance (chi2=48.56, p<0.0001).
CONCLUSIONS: The data and protocol presented in this study would enhance the care and life quality of the NPC patients. Our study showed that a pre-radiotherapy dental care regimen should be conducted simultaneously with the patient's treatment plan to treat the disease. Fluoride tray fabrication is recommended for dentate NPC patients receiving radiation therapy, as it may enhance compliance with dental follow-up.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17976937     DOI: 10.1016/j.anl.2007.08.007

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  5 in total

1.  Anti-caries effect of CPP-ACP in irradiated nasopharyngeal carcinoma patients.

Authors:  Christina P C Sim; Joseph Wee; Ying Xu; Yin-Bun Cheung; Yoke-Lim Soong; David J Manton
Journal:  Clin Oral Investig       Date:  2014-09-27       Impact factor: 3.573

2.  Dental disease before radiotherapy in patients with head and neck cancer: Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients.

Authors:  Michael T Brennan; Nathaniel S Treister; Thomas P Sollecito; Brian L Schmidt; Lauren L Patton; Kusha Mohammadi; Leslie Long Simpson; Helen Voelker; James S Hodges; Rajesh V Lalla
Journal:  J Am Dent Assoc       Date:  2017-12       Impact factor: 3.634

3.  Impact of non-compliance with oral care on radiation caries in head and neck cancer survivors.

Authors:  Sudhir Bhandari; Bhavita Wadhwa Soni; Sushmita Ghoshal
Journal:  Support Care Cancer       Date:  2021-02-01       Impact factor: 3.603

4.  Evaluation of the efficacy of low concentration fluoride gel using custom trays to prevent radiation-related dental caries in patients with head and neck cancer: protocol for a randomised controlled phase III trial (FluCar study).

Authors:  Sakiko Soutome; Souichi Yanamoto; Maho Murata; Yumiko Kawashita; Masako Yoshimatsu; Madoka Funahara; Masahiro Umeda; Toshiyuki Saito
Journal:  BMJ Open       Date:  2020-09-29       Impact factor: 2.692

5.  Saliva substitute mouthwash in nasopharyngeal cancer survivors with xerostomia: a randomized controlled trial.

Authors:  Dayaabaran Marimuthu; Kong Min Han; Mohd Shawal Firdaus Mohamad; Mawaddah Azman
Journal:  Clin Oral Investig       Date:  2020-11-11       Impact factor: 3.573

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.